• Edwards Lifesciences Holding raised its stake in Carvolix above 10% on June 26 via a capital increase subscription.
• The investor held 7,248,035 shares, equal to 11.65% of share capital and 9.07% of voting rights.
• It signaled potential participation in future capital increases, depending on market conditions and Carvolix financing needs.
• Edwards said it does not plan to seek control or board representation.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Carvolix SA published the original content used to generate this news brief on July 06, 2026, and is solely responsible for the information contained therein.